Jean F. Voltaire

Array ( [id] => 9882561 [patent_doc_number] => 08969325 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-03 [patent_title] => 'TRPV1 antagonists' [patent_app_type] => utility [patent_app_number] => 13/716862 [patent_app_country] => US [patent_app_date] => 2012-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 78807 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13716862 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10317258 [patent_doc_number] => 20150202261 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-23 [patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING ANTIPROGESTIN-RESISTANT CANCERS' [patent_app_type] => utility [patent_app_number] => 14/363551 [patent_app_country] => US [patent_app_date] => 2012-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 40932 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14363551 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9757486 [patent_doc_number] => 20140288187 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-25 [patent_title] => 'COCOA-BASED FOOD PRODUCTS' [patent_app_type] => utility [patent_app_number] => 14/361795 [patent_app_country] => US [patent_app_date] => 2012-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12493 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14361795 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9175080 [patent_doc_number] => 20130317066 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-28 [patent_title] => 'PYRIDONE AMIDES AND ANALOGS EXHIBITING ANTI-CANCER AND ANTI-PROLIFERATIVE ACTIVITIES' [patent_app_type] => utility [patent_app_number] => 13/683277 [patent_app_country] => US [patent_app_date] => 2012-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22046 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13683277 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8744628 [patent_doc_number] => 20130084345 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-04 [patent_title] => 'INDIBULIN THERAPY' [patent_app_type] => utility [patent_app_number] => 13/681828 [patent_app_country] => US [patent_app_date] => 2012-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 12275 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13681828 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16413218 [patent_doc_number] => 10821079 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-11-03 [patent_title] => PKC activators and combinations thereof [patent_app_type] => utility [patent_app_number] => 14/357661 [patent_app_country] => US [patent_app_date] => 2012-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 64 [patent_no_of_words] => 22596 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14357661 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9934868 [patent_doc_number] => RE045435 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2015-03-24 [patent_title] => 'Zinc salt compositions for the prevention of dermal and mucosal irritation' [patent_app_type] => reissue [patent_app_number] => 13/673945 [patent_app_country] => US [patent_app_date] => 2012-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14911 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 140 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13673945 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8904865 [patent_doc_number] => 20130172368 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-04 [patent_title] => 'Methods for Treating Hyperuricemia in Patients with Gout Using Halofenate or Halogenic Acid and A Second Urate-Lowering Agent' [patent_app_type] => utility [patent_app_number] => 13/668164 [patent_app_country] => US [patent_app_date] => 2012-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11515 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13668164 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9786351 [patent_doc_number] => 20140303172 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-09 [patent_title] => 'Phosphatidylinositol 3-Kinase Inhibitors for the Treatment of Lymphoproliferative Malignancies' [patent_app_type] => utility [patent_app_number] => 14/355775 [patent_app_country] => US [patent_app_date] => 2012-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12506 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14355775 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9677200 [patent_doc_number] => 08816110 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-26 [patent_title] => 'Polyunsaturated fatty acid monoglycerides, derivatives, and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/666002 [patent_app_country] => US [patent_app_date] => 2012-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 14 [patent_no_of_words] => 9855 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13666002 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8768062 [patent_doc_number] => 20130096099 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-18 [patent_title] => 'METHOD OF TREATING BRAIN CANCER' [patent_app_type] => utility [patent_app_number] => 13/663438 [patent_app_country] => US [patent_app_date] => 2012-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2890 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13663438 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8685107 [patent_doc_number] => 20130053391 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-28 [patent_title] => 'Treatment of T-Cell Lymphoma using 10-propargyl-10-deazaaminopterin' [patent_app_type] => utility [patent_app_number] => 13/663234 [patent_app_country] => US [patent_app_date] => 2012-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3094 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13663234 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10069512 [patent_doc_number] => 09107847 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-08-18 [patent_title] => 'Administration of pyridinedicarboxylic acid compounds for stimulating or inducing the growth of human keratinous fibers and/or arresting their loss' [patent_app_type] => utility [patent_app_number] => 13/662592 [patent_app_country] => US [patent_app_date] => 2012-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6304 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13662592 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8756015 [patent_doc_number] => 20130090320 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-11 [patent_title] => 'METHOD OF TREATING PROSTATE CANCER' [patent_app_type] => utility [patent_app_number] => 13/657888 [patent_app_country] => US [patent_app_date] => 2012-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3468 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13657888 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9756244 [patent_doc_number] => 20140286945 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-25 [patent_title] => 'ENZYME INHIBITOR FOR CANCER TREATMENT' [patent_app_type] => utility [patent_app_number] => 14/352950 [patent_app_country] => US [patent_app_date] => 2012-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 14211 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14352950 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10954683 [patent_doc_number] => 20140357706 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-04 [patent_title] => 'Stearate Compounds' [patent_app_type] => utility [patent_app_number] => 14/350549 [patent_app_country] => US [patent_app_date] => 2012-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 26316 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 26 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14350549 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9739369 [patent_doc_number] => 20140275089 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-18 [patent_title] => '2-Carboxamide Cycloamino Urea Derivatives in Combination with HSP90 Inhibitors for the Treatment of Proliferative Diseases' [patent_app_type] => utility [patent_app_number] => 14/350577 [patent_app_country] => US [patent_app_date] => 2012-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 13720 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14350577 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11256739 [patent_doc_number] => 09481630 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-11-01 [patent_title] => 'Ingenane-type diterpene compound, and pharmaceutical composition for treating or preventing viral infectious diseases containing same' [patent_app_type] => utility [patent_app_number] => 14/352978 [patent_app_country] => US [patent_app_date] => 2012-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 11 [patent_no_of_words] => 6751 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14352978 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9686585 [patent_doc_number] => 20140243351 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-28 [patent_title] => 'DRUG FOR THE TREATMENT OF ALLERGIC RHINITIS COMPRISING PGD2 ANTAGONIST AND HISTAMINE ANTAGONIST' [patent_app_type] => utility [patent_app_number] => 14/347754 [patent_app_country] => US [patent_app_date] => 2012-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12448 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14347754 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8617711 [patent_doc_number] => 20130023023 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-24 [patent_title] => 'ANTI-CANCER AGENT' [patent_app_type] => utility [patent_app_number] => 13/624376 [patent_app_country] => US [patent_app_date] => 2012-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3170 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13624376 [rel_patent_id] =>[rel_patent_doc_number] =>)